失眠与胰岛素抵抗特征的关联:横断面与孟德尔随机化研究
本研究在UK Biobank中采用多变量回归和单样本孟德尔随机化分析,发现失眠症状越频繁与甘油三酯-葡萄糖指数、TG/HDL-C比值及甘油三酯水平升高显著相关,两样本孟德尔随机化验证了类似证据,中介分析提示约25.21%的失眠症状与2型糖尿病关联由胰岛素抵抗介导。
要点
- 失眠症状越频繁与甘油三酯-葡萄糖指数、TG/HDL-C比值及甘油三酯水平升高显著相关。
- 两样本孟德尔随机化获得与主要分析类似的证据。
- 约25.21%的失眠症状与2型糖尿病关联由胰岛素抵抗介导。
核心结论
- 研究提供稳健证据支持更频繁的失眠症状与胰岛素抵抗及其相关特征在不同分析角度下均有关联。
- 这些发现提示失眠症状可作为改善胰岛素抵抗和预防后续2型糖尿病的有前景的靶点。
研究设计与样本
- 在UK Biobank中进行多变量回归和单样本孟德尔随机化分析,随后用两样本孟德尔随机化验证主要分析结果。
- 采用两步孟德尔随机化设计检验胰岛素抵抗在失眠症状导致2型糖尿病通路中的潜在中介效应。
主要发现
- 多变量回归显示更频繁失眠症状与甘油三酯-葡萄糖指数较高相关(β=0.024,P<2.00E-16),单样本孟德尔随机化结果类似(β=0.343,P<2.00E-16)。
- 多变量回归显示更频繁失眠症状与TG/HDL-C比值较高相关(β=0.016,P=1.75E-13),单样本孟德尔随机化结果类似(β=0.445,P<2.00E-16)。
- 多变量回归显示更频繁失眠症状与甘油三酯水平较高相关(β=0.019 log mg/dL,P<2.00E-16),单样本孟德尔随机化结果类似(β=0.289 log mg/dL,P<2.00E-16)。
- 上述结果均经Bonferroni校正,两样本孟德尔随机化获得类似证据。
- 中介分析提示失眠症状与2型糖尿病关联中约四分之一(25.21%)由胰岛素抵抗介导。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Insomnia is associated with insulin resistance (IR) in observational studies; however, whether insomnia is causally associated with IR remains unestablished. OBJECTIVE: This study aims to estimate the causal associations of insomnia with IR and its related traits. METHODS: In primary analyses, multivariable regression (MVR) and 1-sample Mendelian randomization (1SMR) analyses were performed to estimate the associations of insomnia with IR (triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol [TG/HDL-C] ratio) and its related traits (glucose level, TG, and HDL-C) in the UK Biobank. Thereafter, 2-sample MR (2SMR) analyses were used to validate the findings from primary analyses. Finally, the potential mediating effects of IR on the pathway of insomnia giving rise to type 2 diabetes (T2D) were examined using a 2-step MR design. RESULTS: Across the MVR, 1SMR, and their sensitivity analyses, we found consistent evidence suggesting that more frequent insomnia symptoms were significantly associated with higher values of triglyceride-glucose index (MVR, β = 0.024, P < 2.00E-16; 1SMR, β = 0.343, P < 2.00E-16), TG/HDL-C ratio (MVR, β = 0.016, P = 1.75E-13; 1SMR, β = 0.445, P < 2.00E-16), and TG level (MVR, β = 0.019 log mg/dL, P < 2.00E-16, 1SMR: β = 0.289 log mg/dL, P < 2.00E-16) after Bonferroni adjustment. Similar evidence was obtained by using 2SMR, and mediation analysis suggested that about one-quarter (25.21%) of the association between insomnia symptoms and T2D was mediated by IR. CONCLUSIONS: This study provides robust evidence supporting that more frequent insomnia symptoms are associated with IR and its related traits across different angles. These findings indicate that insomnia symptoms can be served as a promising target to improve IR and prevent subsequent T2D.
引用
- Wang X, Zhao C, Feng H, et al. Associations of Insomnia With Insulin Resistance Traits: A Cross-sectional and Mendelian Randomization Study. J Clin Endocrinol Metab. 2023. PMID: 36794917. doi:10.1210/clinem/dgad089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。